Bdh Industries [BDH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Bdh Industries Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bdh Industries Ltd. wins in 9 metrics, Sun Pharmaceutical Industries Ltd. wins in 11 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bdh Industries Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 21.06 36.73 Bdh Industries Ltd.
Price-to-Book Ratio 3.11 5.15 Bdh Industries Ltd.
Debt-to-Equity Ratio 0.04 6.68 Bdh Industries Ltd.
PEG Ratio 0.87 3.59 Bdh Industries Ltd.
EV/EBITDA 14.26 23.61 Bdh Industries Ltd.
Profit Margin (TTM) 12.30% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 13.67% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 13.67% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 13.49% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 10.67% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $145.56M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 2.98% 0.97% Bdh Industries Ltd.
1-Year Return 52.71% 7.10% Bdh Industries Ltd.
Price-to-Sales Ratio (TTM) 2.59 7.05 Bdh Industries Ltd.
Enterprise Value $1.86B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 2.19 6.66 Bdh Industries Ltd.
Gross Profit Margin (TTM) 24.77% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $147 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $18.09 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) 0.21 0.11 Sun Pharmaceutical Industries Ltd.

Bdh Industries Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

BDH
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bdh Industries Ltd.12.41%25.64%21.89%7.78%14.73%7.65%
Sun Pharmaceutical Industries Ltd.-0.09%0.96%-3.84%1.28%0.50%4.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bdh Industries Ltd.52.71%153.63%269.02%364.46%2,121.21%3,639.80%
Sun Pharmaceutical Industries Ltd.7.10%82.23%170.41%143.23%656.74%2,541.29%

Performance & Financial Health Analysis: Bdh Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBDHSUNPHARMA
Market Information
Market Cap i₹2.16B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i6683,903,142
90 Day Avg. Volume i1,7313,253,866
Last Close₹453.20₹1,806.00
52 Week Range₹257.05 - ₹523.75₹1,548.00 - ₹1,916.60
% from 52W High-13.47%-5.77%
All-Time High₹523.75 (Oct 06, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-13.47%-7.87%
Growth Metrics
Quarterly Revenue Growth0.81%0.14%
Quarterly Earnings Growth0.24%0.16%
Financial Health
Profit Margin (TTM) i0.12%0.19%
Operating Margin (TTM) i0.14%0.26%
Return on Equity (TTM) i0.13%0.15%
Debt to Equity (MRQ) i0.046.68
Cash & Liquidity
Book Value per Share (MRQ)₹122.68₹324.46
Cash per Share (MRQ)₹62.75₹115.87
Operating Cash Flow (TTM) i₹227.86M₹110.84B
Levered Free Cash Flow (TTM) i₹92.73M₹109.29B
Dividends
Last 12-Month Dividend Yield i2.98%0.97%
Last 12-Month Dividend i₹9.00₹16.50

Valuation & Enterprise Metrics Analysis: Bdh Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBDH (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i21.0636.73
Forward P/E i52.9229.48
PEG Ratio i0.873.59
Price to Sales (TTM) i2.597.05
Price to Book (MRQ) i3.115.15
Market Capitalization
Market Capitalization i₹2.16B₹3.88T
Enterprise Value i₹1.86B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i2.196.66
Enterprise to EBITDA i14.2623.61
Risk & Other Metrics
Beta i0.210.11
Book Value per Share (MRQ) i₹122.68₹324.46

Financial Statements Comparison: Bdh Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBDH (2025)SUNPHARMA (2025)
Revenue/Sales i648.86M520.41B
Cost of Goods Sold i413.98M121.98B
COGS % of Revenue i63.8%23.4%
Gross Profit i234.88M398.44B
Gross Margin i36.2%76.6%
Research & Development i2.33MN/A
Operating Income (EBIT) i107.01M125.81B
Operating Margin i16.5%24.2%
EBITDA i134.45M167.25B
EBITDA Margin i20.7%32.1%
Pre-Tax Income i124.67M137.52B
Pre-Tax Income % of Revenue i19.2%26.4%
Income Tax i31.94M27.72B
Income Tax % of Revenue i4.9%5.3%
Net Income (Profit) i92.73M109.65B
Profit Margin i14.3%21.1%

Balance Sheet & Liquidity Metrics

MetricBDH (2025)SUNPHARMA (2025)
Cash & Equivalents i307.12M102.69B
Total Current Assets i667.49M526.24B
Total Current Assets % of Revenue i102.9%101.1%
Total Current Liabilities i169.17M181.94B
Total Current Liabilities % of Revenue i26.1%35.0%
Long-Term Debt iN/A3.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i687.62M724.86B
Retained Earnings i457.59M578.62B
Retained Earnings % of Revenue i70.5%111.2%
Property, Plant & Equipment i146.88M100.36B

Cash Flow Statement Comparison

MetricBDH (2025)SUNPHARMA (2025)
Operating Cash Flow i227.86M110.84B
Operating Cash Flow % of Revenue i35.1%21.3%
Capital Expenditures i-2.15M-20.68B
Free Cash Flow i145.56M119.44B
FCF Margin i22.4%23.0%
Debt Repayment i-77.11M-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricBDHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i5.76M2.40B
Float Shares i2.26M1.07B
% Held by Insiders i57.26%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i42.74%15.69%

Dividend Analysis & Yield Comparison: Bdh Industries Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricBDHSUNPHARMA
Last 12-Month Dividend i₹9.00₹16.50
Last 12-Month Dividend Yield i2.98%0.97%
3-Year Avg Annual Dividend i₹5.53₹17.33
3-Year Avg Dividend Yield i1.92%0.51%
3-Year Total Dividends i₹16.60₹52.00
Ex-Dividend DateAug 01, 2025Feb 05, 2026